<DOC>
	<DOC>NCT00225485</DOC>
	<brief_summary>Phase III study evaluating Effexor XR in elderly patients with major depression.</brief_summary>
	<brief_title>Study Evaluating Effexor XR in Elderly Patients With Major Depression.</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<criteria>Patients diagnosed with major depression based on DSMIVTR Patients having minimal total score of 18 on the HAMD17 and minimal score of 2 on the item of "depressed mood" of HAMD at baseline Patients with schizophrenia or any other psychotic disorder Patients with history or presence of bipolar disorder</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>Depression</keyword>
</DOC>